Niavin Trigger Point Relief Addresses Pain at Its Source

Posted by john on August 26th, 2007 — in Ultram News

New Topical Formula Provides Pain Relief Alternative To Prescription and Over-The-Counter Medications LOS ANGELES, Aug. 21 /PRNewswire/ — The statistics on pain are, well, painful. Nine in ten Americans report suffering regularly from various physical aches and pains with chronic, debilitating pain found to affect more than 44 million American households*. There is a glut […]

People with advanced cancer pray that their pain be well-controlled

Posted by john on August 19th, 2007 — in Ultram News

But despite the advances in pain management over the years, significant cancer pain is still present in more than 70% of patients. “In good centres, pain is well managed,” says Dr. Allan Gordon, director of the Wasser Pain Management Centre at Mount Sinai Hospital in Toronto. “But there is still room for improvement.” Lots, it […]

Novartis pulls painkiller from Australian market after deaths

Posted by john on August 15th, 2007 — in Ultram News

BASEL, Switzerland: Novartis AG said it has removed its pain relief drug Prexige from the Australian market, which the national drug regulator called for after two patients died and two others had to undergo liver transplants.
Patients in Australia should stop taking the medication immediately, return any remaining tablets to their pharmacist and seek medical advice […]

Innovative Treatment Option for Cancer Pain Now Available in Canada

Posted by john on August 10th, 2007 — in Ultram News

Today, Bayer Inc., a subsidiary of Bayer AG, and GW Pharmaceuticals announced that Health Canada has approved SATIVEX(R), a cannabis derived pharmaceutical treatment, as adjunctive analgesic treatment in adult patients with advanced cancer who experience moderate to severe pain during the highest tolerated dose of strong opioid therapy for persistent background pain. SATIVEX, the only […]